Skip to content. | Skip to navigation

Personal tools
Sections
You are here: Home topics Pharmaceuticals
Document Actions

Pharmaceuticals Policy in the EU

Latest news on the pharmaceutical policies of the European Union.

Pharmaceuticals in the EU 25 August 2006, 12:35 CET
European Union action in the pharmaceutical products sector is basically composed of two types of measures relating to industrial policy and the smooth operation of the internal market. These involve the harmonisation of technical requirements and strengthening the competitiveness of the European pharmaceutical industry.

EU Pharmaceuticals portal 08 August 2006, 10:42 CET
Since 1985, a score of European Community directives have been adopted with the aim of achieving a single, EU-wide market for pharmaceuticals.

European cosmetics industry 03 January 2007, 18:44 CET
The European cosmetics industry has a value of output of more than EUR 35 billion; is highly innovative, with major cosmetic companies replacing or reformulating around 25% of their products every year; and employs over 150.000 Europeans directly, with a further 350.000 jobs created indirectly in retail, distribution and transport. The main regulatory framework which aims at ensuring the free circulation of cosmetic products in the internal market and safeguarding the safety of cosmetic products placed on the EU-market is the Council Directive 76/768 of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products ("Cosmetics Directive").

Medicinal products register 08 August 2006, 10:33 CET
European Community register of medicinal products for human use

EU Directive on Dangerous Substances 07 August 2006, 17:54 CET
Ehe EU Directive on Dangerous Substances was a response to a need to ensure the protection of public health, in particular the health of workers handling dangerous substances.

European Agency for the Evaluation of Medicinal Products - EMEA 19 July 2007, 21:22 CET
The European Agency for the Evaluation of Medicinal Products (EMEA) is a decentralised body of the European Union. It has its headquarters in London since January 1995. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.

EU trade - access to essential medecines 05 August 2006, 23:08 CET
Infectious diseases are responsible for almost half of all deaths in developing countries, and half of these diseases are caused by HIV (AIDS), tuberculosis and malaria. More than 2 billion inhabitants of the world do not have regular access to adequate treatment and cure. AIDS, tuberculosis and malaria alone kill 5 million people each year mostly in developing countries. European Union initiatives

EU Influenza Research 03 January 2007, 18:44 CET
As news reaches the public about the spread of H5N1 'avian' influenza virus from Asia to Europe and Africa, it raises some questions. What is the difference between seasonal, avian and pandemic influenza? Is Europe prepared for a pandemic? What are scientists and, especially, EU-funded projects doing to help? This website presents current EU-funded flu and virus research – both human and pandemic strains and animal strains – and future initiatives. It also features profiles of some key personnel engaged in the battle against this deadly opponent.